©The Author(s) 2025.
World J Gastroenterol. Nov 14, 2025; 31(42): 111708
Published online Nov 14, 2025. doi: 10.3748/wjg.v31.i42.111708
Published online Nov 14, 2025. doi: 10.3748/wjg.v31.i42.111708
Figure 3 General situation of mice.
A: Effects of Yiyi Fuzi Baijiang powder on body weight of mice with ulcerative colitis-induced during the 21-day monitoring period; B: Survival rate from different groups during the 21-day monitoring period; C: Disease activity index (DAI) score of mice in different groups 7 days after dextran sulfate sodium (DSS) intervention; D: DAI score of mice in different groups 14 days after DSS intervention; E: DAI score of mice in different groups 21 days after DSS intervention; F: Colitis severity indicated by DAI score. bP < 0.01. Data are expressed as the mean ± SD, n = 7-10. Con: Control; Mod: Model; YFB: Yiyi Fuzi Baijiang powder; DAI: Disease activity index.
- Citation: Zhang LK, Gu WC, Chen J. Unveiling Yiyi Fuzi Baijiang powder: Microecological and network pharmacology approach to ulcerative colitis treatment. World J Gastroenterol 2025; 31(42): 111708
- URL: https://www.wjgnet.com/1007-9327/full/v31/i42/111708.htm
- DOI: https://dx.doi.org/10.3748/wjg.v31.i42.111708